Cargando…

Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation

Natriuretic peptides (NPs) have become important diagnostic and prognostic biomarkers in cardiovascular diseases, particularly in heart failure (HF). Diagnosis and management of coronary artery disease and atrial fibrillation (AF) can also be guided by NP levels. When interpreting NP levels, however...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baba, Masako, Yoshida, Kentaro, Ieda, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600257/ https://www.ncbi.nlm.nih.gov/pubmed/31185605 http://dx.doi.org/10.3390/ijms20112824

Ejemplares similares

Atrial Natriuretic Peptides as a Bridge between Atrial Fibrillation, Heart Failure, and Amyloidosis of the Atria
por: Rahbar Kouibaran, Farzad, et al.
Publicado: (2023)

Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients
por: Nasab Mehrabi, Entezar, et al.
Publicado: (2023)

Interactions Between Atrial Fibrillation and Natriuretic Peptide in Predicting Heart Failure Hospitalization or Cardiovascular Death
por: Brady, Paul F., et al.
Publicado: (2022)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure
por: Fu, Shihui, et al.
Publicado: (2018)

Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort
por: Geelhoed, Bastiaan, et al.
Publicado: (2020)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

Clinical Significance of B-type Natriuretic Peptide in Heart Failure
por: Yoo, Byung-Su
Publicado: (2014)

N‐terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure
por: Schnorbach, Johannes, et al.
Publicado: (2019)

Impact of catheter ablation and subsequent recurrence of atrial fibrillation on glucose status in patients undergoing continuous glucose monitoring
por: Baba, Masako, et al.
Publicado: (2023)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Brain Natriuretic Peptide Is a Powerful Predictor of Outcome in Stroke Patients with Atrial Fibrillation
por: Maruyama, Kenji, et al.
Publicado: (2017)

Atrial Fibrillation and Heart Failure
por: Bergau, Leonard, et al.
Publicado: (2022)

Relationship of diabetes, heart failure, and N‐terminal pro‐B‐type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation
por: Hofer, Felix, et al.
Publicado: (2022)

Clinical Applications of Natriuretic Peptides in Assessment of Valvular Heart Disease
por: Sharma, Abhishek, et al.
Publicado: (2015)

Brain Natriuretic Peptide Biomarkers in Current Clinical and Therapeutic Scenarios of Heart Failure
por: Alcidi, Gianmarco, et al.
Publicado: (2022)

Molecular Mechanism of Blood Pressure Regulation through the Atrial Natriuretic Peptide
por: Tokudome, Takeshi, et al.
Publicado: (2022)

The Effects of Exercise on Natriuretic Peptides in Individuals without Heart Failure
por: Hamasaki, Hidetaka
Publicado: (2016)

Diagnostic accuracy of left atrial remodelling and natriuretic peptide levels for preclinical heart failure
por: Tsai, Jui‐Peng, et al.
Publicado: (2019)

Can atrial natriuretic peptides measurement diagnose heart failure at different age groups?
por: Golabchi, Allahyar
Publicado: (2012)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Natriuretic peptide pathways in heart failure: further therapeutic possibilities
por: Sangaralingham, S Jeson, et al.
Publicado: (2022)

Diagnostic value of brain natriuretic peptide and β-endorphin plasma concentration changes in patients with acute left heart failure and atrial fibrillation
por: Feng, Shao-Dan, et al.
Publicado: (2017)

Do the Natriuretic Peptides Cause Atrial Fibrillation or is it Not So Black and White?
por: Richards, Arthur Mark
Publicado: (2019)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Atrial Natriuretic Peptide Single Nucleotide Polymorphisms in Patients with Nonfamilial Structural Atrial Fibrillation
por: Francia, Pietro, et al.
Publicado: (2013)

The Use of Brain Natriuretic Peptide in the Evaluation of Heart Failure in Geriatric Patients
por: Marinescu, Mihai, et al.
Publicado: (2023)

Predictors of Recurrence after Catheter Ablation of Paroxysmal Atrial Fibrillation in Different Follow-Up Periods
por: Baba, Masako, et al.
Publicado: (2020)

Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure—A Comparative Review
por: Gangnus, Tanja, et al.
Publicado: (2019)

Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure
por: Goltsman, Ilia, et al.
Publicado: (2019)

Neuroendocrine hormone status and diuretic response to atrial natriuretic peptide in patients with acute heart failure
por: Matsumoto, Shingo, et al.
Publicado: (2022)

Atrial natriuretic peptide stimulates autophagy/mitophagy and improves mitochondrial function in chronic heart failure
por: Raffa, Salvatore, et al.
Publicado: (2023)

Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications
por: Yamagami, Fumi, et al.
Publicado: (2019)

Biomarkers in the clinical management of patients with atrial fibrillation and heart failure
por: Koniari, Ioanna, et al.
Publicado: (2021)

Interpretation and Use of Natriuretic Peptides in Non-Congestive Heart Failure Settings
por: Tsai, Shih-Hung, et al.
Publicado: (2010)

Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure
por: Pandit, Sandeep V., et al.
Publicado: (2016)

Atrial Fibrillation Ablation in Heart Failure Patients
por: Derndorfer, Michael, et al.
Publicado: (2021)

Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure
por: Palazzuoli, A, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ghjthhlaba2mn9s6t85bp9cpgu